Product/Composition:- | Clotrimazole Topical Creams/Ointments |
---|---|
Strength:- | 1%, 2% |
Form:- | Topical Creams/Ointments |
Reference Brands:- | Lotrimin(US); Canesten(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Clotrimazole topical creams and ointments inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and damaging fungal cell membranes. They effectively treat dermatophyte and yeast infections, offering benefits like targeted application, fast relief, broad-spectrum activity, and minimal systemic side effects, making them a reliable choice for superficial fungal infections.
Clotrimazole topical creams and ointments are widely approved in the EU and US for treating fungal skin infections. In the EU, brands like Canesten are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA-approved clotrimazole products such as Lotrimin are backed by comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for approval, ensuring product safety and efficacy. For expert assistance with regulatory dossiers, compliance, and submissions, visit PharmaTradz. We support smooth market access for clotrimazole topical formulations, helping you meet European and American standards for safe, effective antifungal treatment.